CIGB-258 Exerts Potent Anti-Inflammatory Activity against Carboxymethyllysine-Induced Acute Inflammation in Hyperlipidemic Zebrafish via the Protection of Apolipoprotein A-I

Inflammation and atherosclerosis are intimately associated via the production of dysfunctional high-density lipoproteins (HDL) and modification of apolipoprotein (apo) A-I. A putative interaction between CIGB-258 and apoA-I was investigated to provide mechanistic insight into the protection of HDL. The protective activity of CIGB-258 was tested in the CML-mediated glycation of apoA-I. The in vivo anti-inflammatory efficacy was compared in paralyzed hyperlipidemic zebrafish and its embryo in the presence of CML. Treatment of CML induced greater glycation extent of HDL/apoA-I and proteolytic degradation of apoA-I. In the presence of CML, however, co-treatment of CIGB-258 inhibited the glycation of apoA-I and protected the degradation of apoA-I, exerting enhanced ferric ion reduction ability. Microinjection of CML (500 ng) into zebrafish embryos resulted in acute death with the lowest survivability with severe developmental defects with interleukin (IL)-6 production. Conversely, a co-injection of CIGB-258 or Tocilizumab produced the highest survivability with a normal development speed and morphology. In hyperlipidemic zebrafish, intraperitoneal injection of CML (500 μg) caused the complete loss of swimming ability and severe acute death with only 13% survivability 3 h post-injection. A co-injection of the CIGB-258 resulted in a 2.2-fold faster recovery of swimming ability than CML alone, with higher survivability of approximately 57%. These results suggest that CIGB-258 protected hyperlipidemic zebrafish from the acute neurotoxicity of CML. Histological analysis showed that the CIGB-258 group had 37% lower infiltration of neutrophils in hepatic tissue and 70% lower fatty liver changes than those of the CML-alone group. The CIGB-258 group exhibited the smallest IL-6 expression in the liver and the lowest blood triglyceride level. CIGB-258 displayed potent anti-inflammatory activity in hyperlipidemic zebrafish by inhibiting apoA-I glycation, promoting rapid recovery from the paralysis of CML toxicity and suppression of IL-6, and lowering fatty liver changes.

[1]  Kyung-Hyun Cho,et al.  Anti-Inflammatory Activity of CIGB-258 against Acute Toxicity of Carboxymethyllysine in Paralyzed Zebrafish via Enhancement of High-Density Lipoproteins Stability and Functionality , 2022, International journal of molecular sciences.

[2]  Ju-Hyun Kim,et al.  Long-Term Alcohol Consumption Caused a Significant Decrease in Serum High-Density Lipoprotein (HDL)-Cholesterol and Apolipoprotein A-I with the Atherogenic Changes of HDL in Middle-Aged Korean Women , 2022, International journal of molecular sciences.

[3]  Wenjie Zhu,et al.  Apolipoprotein A1 Modulates Teff/Treg Balance Through Scavenger Receptor Class B Type I-Dependent Mechanisms in Experimental Autoimmune Uveitis , 2022, Investigative ophthalmology & visual science.

[4]  E. Mariman,et al.  Plasma Levels of Triglycerides and IL-6 Are Associated With Weight Regain and Fat Mass Expansion , 2022, The Journal of clinical endocrinology and metabolism.

[5]  M. Hellwig,et al.  Glycation of N-ε-carboxymethyllysine , 2021, European Food Research and Technology.

[6]  Mayssa H. Mokalled,et al.  Assessment of Swim Endurance and Swim Behavior in Adult Zebrafish. , 2021, Journal of visualized experiments : JoVE.

[7]  Ju-Hyun Kim,et al.  Ozonated Sunflower Oil Exerted Protective Effect for Embryo and Cell Survival via Potent Reduction Power and Antioxidant Activity in HDL with Strong Antimicrobial Activity , 2021, Antioxidants.

[8]  B. Lambrecht,et al.  Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial , 2021, The Lancet Respiratory Medicine.

[9]  Christina Sisliyan,et al.  Hyperlipidemia and Obesity’s Role in Immune Dysregulation Underlying the Severity of COVID-19 Infection , 2021, Clinics and practice.

[10]  C. Sensi,et al.  Higher Levels of C-Reactive Protein and Ferritin in Patients with Overweight and Obesity and SARS-CoV-2-Related Pneumonia , 2021, Obesity Facts.

[11]  M. Constantin,et al.  High serum level of interleukin-6 is linked with dyslipidemia in oral lichen planus , 2021, Experimental and therapeutic medicine.

[12]  G. Marsche,et al.  Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins , 2021, Biomedicines.

[13]  Neng Zhu,et al.  Targeting HDL in tumor microenvironment: New hope for cancer therapy , 2021, Journal of cellular physiology.

[14]  M. Béquet-Romero,et al.  CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients , 2021, Cell Stress and Chaperones.

[15]  In-Chul Lee,et al.  Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity , 2021, Antioxidants.

[16]  C. June,et al.  Cytokine Storm , 2020, The New England journal of medicine.

[17]  Y. Oo,et al.  The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations , 2020, Frontiers in Immunology.

[18]  J. Gustine,et al.  Immunopathology of Hyperinflammation in COVID-19 , 2020, The American Journal of Pathology.

[19]  B. Lipworth,et al.  Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[20]  J. Roliński,et al.  Serum concentration of interleukin 6 is related to inflammation and dyslipidemia in patients with psoriasis , 2020, Postepy dermatologii i alergologii.

[21]  Zhiyong Gong,et al.  The neurotoxicity of Nε-(carboxymethyl)lysine in food processing by a study based on animal and organotypic cell culture. , 2019, Ecotoxicology and environmental safety.

[22]  K. Artinger,et al.  The conserved and divergent roles of Prdm3 and Prdm16 in zebrafish and mouse craniofacial development , 2019, bioRxiv.

[23]  E. Drakos,et al.  Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer , 2019, Cancers.

[24]  F. Greten,et al.  Inflammation and Cancer: Triggers, Mechanisms, and Consequences. , 2019, Immunity.

[25]  Hao Xu,et al.  Studies on mechanism of free Nε‐(carboxymethyl)lysine‐induced toxic injury in mice , 2019, Journal of biochemical and molecular toxicology.

[26]  Ira Tabas,et al.  Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities , 2019, Nature Reviews Cardiology.

[27]  F. Gunzer,et al.  Metabolization of the Advanced Glycation End Product N-ε-Carboxymethyllysine (CML) by Different Probiotic E. coli Strains. , 2019, Journal of agricultural and food chemistry.

[28]  L. González,et al.  CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis , 2018, Clinical Rheumatology.

[29]  Kyung-Hyun Cho,et al.  The Ability of Different Ketohexoses to Alter Apo-A-I Structure and Function In Vitro and to Induce Hepatosteatosis, Oxidative Stress, and Impaired Plasma Lipid Profile in Hyperlipidemic Zebrafish , 2018, Oxidative medicine and cellular longevity.

[30]  Kyung-Hyun Cho,et al.  Blood Pressure Lowering Effect of Cuban Policosanol is Accompanied by Improvement of Hepatic Inflammation, Lipoprotein Profile, and HDL Quality in Spontaneously Hypertensive Rats , 2018, Molecules.

[31]  S. Sacco,et al.  The Role of Inflammation in Neurological Disorders. , 2018, Current pharmaceutical design.

[32]  L. Silengo,et al.  APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis , 2017, Clinical and Experimental Medicine.

[33]  Zhiyong Gong,et al.  Toxicological evaluation of advanced glycation end product Nε-(carboxymethyl)lysine: Acute and subacute oral toxicity studies. , 2016, Regulatory toxicology and pharmacology : RTP.

[34]  Jae-Yong Kim,et al.  Fructated apolipoprotein A-I exacerbates cellular senescence in human umbilical vein endothelial cells accompanied by impaired insulin secretion activity and embryo toxicity. , 2016, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[35]  Xiang-An Li,et al.  HDL in sepsis – risk factor and therapeutic approach , 2015, Front. Pharmacol..

[36]  Jie Chen,et al.  Increased accumulation of protein-bound N(ε)-(carboxymethyl)lysine in tissues of healthy rats after chronic oral N(ε)-(carboxymethyl)lysine. , 2015, Journal of agricultural and food chemistry.

[37]  G. Norata,et al.  HDL in innate and adaptive immunity. , 2014, Cardiovascular research.

[38]  S. Subramanian,et al.  Apolipoprotein AI and High-Density Lipoprotein Have Anti-Inflammatory Effects on Adipocytes via Cholesterol Transporters: ATP-Binding Cassette A-1, ATP-Binding Cassette G-1, and Scavenger Receptor B-1 , 2013, Circulation research.

[39]  Kyung-Hyun Cho,et al.  A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins. , 2011, Fish & shellfish immunology.

[40]  D. Klatzmann,et al.  An altered peptide ligand corresponding to a novel epitope from heat-shock protein 60 induces regulatory T cells and suppresses pathogenic response in an animal model of adjuvant-induced arthritis , 2011, Autoimmunity.

[41]  P. Barter,et al.  Anti-inflammatory effects of apolipoprotein A-I in the rabbit. , 2010, Atherosclerosis.

[42]  A. Tall,et al.  ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation , 2010, Science.

[43]  Dong-gu Shin,et al.  Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[44]  P. Barter,et al.  Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[45]  Ki-yong Kim,et al.  Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence. , 2010, Biochemical and biophysical research communications.

[46]  D. Sviridov,et al.  Reconstituted HDL: a therapy for atherosclerosis and beyond , 2009 .

[47]  Man-ping Wu,et al.  Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid. , 2008, Cytokine.

[48]  C. Heizmann,et al.  N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. , 2008, Molecular nutrition & food research.

[49]  Utpal Banerjee,et al.  Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint , 2008, Nature Genetics.

[50]  S. Bandinelli,et al.  High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study. , 2007, Atherosclerosis.

[51]  Mitchell H. Grayson,et al.  The Immune Response: Basic and Clinical Principles , 2006 .

[52]  T. Kishimoto,et al.  Interleukin-6 : discovery of a pleiotropic cytokine , 2022 .

[53]  R. Terkeltaub,et al.  Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics , 2006, Arthritis research & therapy.

[54]  D. Taramelli,et al.  High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli. , 2005, Biochimica et biophysica acta.

[55]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[56]  S. Drusch,et al.  Selective fortification of lysinoalanine, fructoselysine and Nε-carboxymethyllysine in casein model systems , 2001 .

[57]  J. Strain,et al.  Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. , 1999, Methods in enzymology.

[58]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[59]  K. Feingold,et al.  Interleukin-6 stimulates hepatic triglyceride secretion in rats. , 1995, Endocrinology.

[60]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS , 1994, The Journal of experimental medicine.

[61]  B. Shilton,et al.  Role of fructose in glycation and cross-linking of proteins. , 1988, Biochemistry.

[62]  H. Brewer,et al.  Isolation and characterization of apolipoproteins A-I, A-II, and A-IV. , 1986, Methods in enzymology.

[63]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.